Hyperbaric Oxygen Therapy References

1. Neubauer RA, Walker M. Hyperbaric Oxygen Therapy. Avery Publishing Group, NY, 1998:ix.

2. Gabb G, Robin ED. Hyperbaric Oxygen: a therapy in search of diseases. Chest. 1987; 92:1074-82.

3. Churchill-Davidson I, Sanger C, Thomlinson. High-pressure oxygen and radiotherapy. Lancet. 1955;1:1091-95.

4. Boerema I, Kroll JA, Meijne NG, Lokin E, et al. High atmospheric pressure as an aid to cardiac surgery. Arch Chir Neerl. 1956;8:193-211.

5. Davis JC, Hunt TK. Hyperbaric Oxygen Therapy. Undersea Medical Society, Bethesda, 1977.

6. Hyperbaric Oxygen Committee. Hyperbaric Oxygen Therapy: A Committee Report. Undersea and Hyperbaric Medical Society, Bethesda, 1996.

7. Dolan MC. Carbon Monoxide Poisoning. Can Med Assoc J. 1985;133:392.

8. U.S. Public Health Service: Vital Statistics of the United States, Washington, DC, Government Printing Office, 1976.

9. Myers RAM. Do arterial blood gasses have value in prognosis and treatment decisions in carbon monoxide poisoning? Crit Care Med. 1989:1720:139-142.

10. Myers RAM, Messier LD, Jones DW, Cowley RA. New direction in the research and treatment decisions in carbon monoxide poisoning. Am J Emerg Med. 1983;2:226.

11. End E, Long CW. Oxygen under pressure in carbon monoxide poisoning. J Ind Hyg Toxicol. 1942;24:302-6.

12. Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science. 1950;111:652-4.

13. Britten JS, Myers RAM. Effects of hyperbaric treatment on carbon monoxide elimination in humans. Undersea Biomed Res. 1985; 12:431-8.

14. Haldane JBS. Carbon monoxide as a tissue poison. Biochem J. 1957; 21:1068-1075.

15. Meyer-Witting M, Helps SC, Gorman DF. Acute CO exposure and cerebral blood flow in rabbits. Anaesth Intens Care. 1991;19:373-7.

16. Thom SR. Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol Appl Pharmacol. 1990; 105:340-4.

17. Thom SR. Functional inhibition of leukocyte ?2-integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol. 1993;123:248-256.

18. Olson KR, Seger D. Hyperbaric oxygen for carbon monoxide poisoning: Does it really work? Ann Emerg Med. 1995; 25:535-7.

19. Seger D. The science (or lack thereof) in the treatment of carbon monoxide poisoning. Am J Emerg Med. 1993;11:616-8.

20. Whorton MD. Carbon monoxide intoxication: A review of 14 patients. J Am Coll Emerg Physicians. 1976;5:505.

21. Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. J Toxicol Clin Toxicol. 1982;19:297.

22. Smith JS, Brandon S. Morbidity from acute carbon monoxide poisoning at three year follow-up. Br Med J. 1973;1:318.

23. Youngberg JT, Myers RAM, Use of hyperbaric oxygen therapy in carbon monoxide, cyanide and sulfide intoxication. Hyperbaric Oxygen Therapy: A Critical Review. Camporesi EM and Barker AC (Eds.) Undersea and Hyperbaric Medical Society Bethesda, 1991:23-53.

24. Hadley M. Coal-gas poisoning and cardiac sequelae. Br Heart J. 1952;14:534-6.

25. Krantz T, Thisted P, Strom J, Sorrenson MB. Acute carbon monoxide poisoning. Acta Anaesthesiol Scan. 1988;32:278-282.

26. Norkool DM, Kirkpatrick JN. Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: A review of 115 cases. Ann Emerg Med. 1985;14:1168-1171.

27. Min SK. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr Scand. 1986;73:80-6.

28. Birky MM, Clarke FB. Inhalation of toxic products from fires. Bull NY Acad Med 1981;57:997-1013.

29. Clark CJ, Campbell D, Reid WH. Blood carboxyhemoglobin and cyanide levels in fire survivors. Lancet. 1981:1:1332-5.

30. Mohler SR. Air crash survival: Injuries and evacuation toxic hazards. Aviat Space Environ Med. 1975;46:86-8.

31. Terrill JB, Montogomery RR, Reinhardt CF. Toxic gasses from fires. Science. 1978; 200:1343-7.

32. Symington IS. Cyanide exposure in fires. Lancet. 1978;2:91-2.

33. Hart GB, Strauss MB, Lennon PA, Whitcraft DD. Treatment of smoke inhalation by hyperbaric oxygen. J Emerg Med. 1985;3:211-5.

34. Norris JC, Moore SJ, Hume AS. Synergistic lethality induced by the combination of carbon monoxide and cyanide. Toxicology. 1986;40:121-9.

35. Barillo DJ, Goode R, Rush BF Jr, Lin RL, et al. Lack of correlation between carboxyhemoglobin and cyanide in smoke inhalation injury. Curr Surg. 1986;43:421-3.

36. Ivanov KP. The effect of elevated oxygen pressure on animals poisoned with potassium cyanide. Pharmacol Toxicology. 1959;22:476-9.

37. Skene WG, Norman JN, Smith. Effect of hyperbaric oxygen in cyanide poisoning. In: Brown IW, Cox B (eds) Proceedings of the Third International Congress on Hyperbaric Medicine, Washington DC: National Academy of Sciences-National Research Council, 1966:705- 710.

38. Takano T, Miyazaki Y, Nashimoto I, Kobayashi K. Effect of hyperbaric oxygen on cyanide intoxication: In situ changes in intracellular oxidation reduction. Undersea Biomed Res. 1980; 7:191-7.

39. Cope C. The importance of oxygen in the treatment of cyanide poisoning. JAMA. 1961;175:1061-4.

40. Isom GE, Way JL. Effect of oxygen on cyanide intoxication: VI. Reactivation of cyanide inhibited glucose metabolism. J Pharmacol Exp Ther. 1974;189:235-243.

41. Burrows GE, Way JL. Cyanide intoxication in sheep. Therapeutic value of oxygen or cobalt. Am J Vet Res. 1977;38:223-227.

42. Way JL, Gibbon SL, Sheehy M. The effect of oxygen on cyanide intoxication. I. Prophylactic protection. J Pharmacol Exp Ther. 1966; 153:381-5.

43. Sheehy M, Way JL. The effect of oxygen on cyanide intoxication. III. Mithridate. J Pharmacol Exp Ther. 1968; 161:163-8.

44. Goldstein GM, Doull J. Treatment of nitrite-induced methemoglobinemia with hyperbaric oxygen. Proc Soc Exp Biol Med. 1971;138:137-9.

45. Jain KK. Textbook of Hyperbaric Medicine. Hogrefe & Huber Publishers, NY, 1990, 165.

46. Divers Alert Network. Report on Decompression Illness and Diving Fatalities: The DAN Annual Review of Recreational Scuba Diving Injuries and Fatalities Based on 1996 Data. Durham, NC. 1998.

47. Francis TJR, Dutka AJ, Hallenbeck JM. Pathophysiology of Decompression Sickness. In Bove AA, Davis JC (eds). Diving Medicine, WB Saunders Co., Philadelphia, 1990. 172.

48. Gardette B. Correlation between decompression sickness and circulating bubbles in 232 divers. Undersea Biomed Res. 1979; 6:99-107.

49. Nashimoto I, Gotoh Y. Relationship between precordial doppler ultrasound records and decompression sickness. In Shilling CW, Beckett MW (eds). Underwater Physiology VI. Bethesda. FAESB, 1978;497- 501.

50. Powell MR, Johansen DC. Ultrasound monitoring and decompression sickness. In Shilling CW, Beckett MW (eds). Underwater Physiology VI. Bethesda. FAESB, 1978;503-510.

51. Francis TJR, Dutka AJ, Hallenbeck JM. Pathophysiology of Decompression Sickness. In Bove AA, Davis JC (eds). Diving Medicine, WB Saunders Co., Philadelphia, 1990. 177.

52. Kidd DJ, Elliott DH. Clinical manifestations and treatment of decompression sickness in divers. In Bennett PB, Elliott DH (eds). The Physiology and Medicine of Diving and Compressed Air Work. Baillere Tindall and Cassell, London, 1969. 464-490.

53. Hallenbeck JM, Bove AA, Elliott DH. Decompression sickness studies. In Lambertsen CJ (ed). Underwater Physiology V. Bethesda, FASEB, 1976, 273-286.

54. Bove AA. The basis for drug therapy in decompression sickness. Undersea Biomed Res.1982;9:91-111.

55. Butler BD, Laine, GA, Lieman BC, Warters D, et al. Effect of Trendelenberg position on the distribution of arterial emboli in dogs. Ann Thoracic Surg. 1988;45:198-202.

56. Dutka AJ. Therapy for dysbaric central nervous system ischemia: Adjuncts to recompression. In Bennett PB, Moon RE. Diving Accident Management. Undersea and Hyperbaric Medical Society, Bethesda, 1990, 222-234.

57. American Heritage Dictionary. Boston: Houghton Mifflin Co., 1994.

58. Simpson I. Compressed air as a therapeutic agent in the treatment of consumption, asthma, chronic bronchitis and other diseases. Edinburgh: Sutherland & Knox, 1857.

59. Fontaine JA Emploi chirurgical de l'air comprime. Union Med. 28:445, 1879.

60. Jacobson JH and others. The historical perspective of hyperbaric therapy. Annals of the New York Academy. of Sciences 117:651, 1965.

61. Sheridan RL, Shank ES. Hyperbaric oxygen treatment: A brief overview of a controversial topic. Journal of Trauma 47:426-435, 1999.

62. Triger M. Letter to Monsieur Arago. Compte Rendus de l'Academie des Sciences. Paris. 20:445, 1845.

63. Pol M., Watelle M. Memoire sur des effets de commpression de l'air applique creusement de puits houille. Annales Hygiene Hygiene Publique et de Medicine Legale. Second Series 1:241, 1854.

64. Bert P and others. La Pression barométrique, recherches de physiologie expérimentale. Paris: Masson, 1878.

65. Moir EW. Tunnelling by compressed air. Journal of the Society of Arts 44:567, 1896.

66. Boerema I and others. High atmospheric pressure as an aid to cardiac surgery. Archivum Chirurgicum Neerlandicum 8:193, 1956.

67. Brummelkamp, W.H., et al. (1961). Treatment of anaerobic infections (clostridial myositis) by drenching tissues with oxygen under high atmospheric pressure. Surgery 49:299, 1961.

68. Smith G, Sharp GR. Treatment of coal gas poisoning with oxygen at two atmospheres pressure. Lancet 1:816, 1962.

69. National Academy of Sciences, National Research Council. Fundamentals of Hyperbaric Medicine, Publication #1298, 1966.

70. Bild DE, Selby JV, Sinnock P, Browner WS,Braveman P, Showstack JA. Lower-extremityamputation in people with diabetes. Epidemiologyand prevention. Diabetes Care. 1989;12(1):24-31.

71. Gregg EW, Sorlie P, Paulose-Ram R, et al.Prevalence of lower-extremity disease in theUS adult population >=40 years of age with andwithout diabetes: 1999-2000 national health andnutrition examination survey. Diabetes Care.2004;27(7):1591-7.

72. Jeffcoate WJ, Harding KG. Diabetic foot ulcers.Lancet. 2003;361(9368):1545-51.

73. Roeckl-Wiedmann I, Bennett M, Kranke P.Systematic review of hyperbaric oxygen in themanagement of chronic wounds. Br J Surg.2005;92(1):24-32.

74. Kranke P, Bennett M, Roeckl-Wiedmann I, DebusS. Hyperbaric oxygen therapy for chronic wounds.Cochrane Database Syst Rev. 2004(2):CD004123.

75. Guo S, Counte MA, Gillespie KN, Schmitz H.Cost-effectiveness of adjunctive hyperbaric oxygenin the treatment of diabetic ulcers. Int J TechnolAssess Health Care. 2003;19(4):731-7.

76. Kessler L, Bilbault P, Ortega F, et al. Hyperbaricoxygenation accelerates the healing rate ofnonischemic chronic diabetic foot ulcers: aprospective randomized study. Diabetes Care.2003;26(8):2378-82.

77. Abidia A, Laden G, Kuhan G, et al. The role ofhyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomisedcontrolledtrial. Eur J Vasc Endovasc Surg.2003;25(6):513-8.

78. Kalani M, Jorneskog G, Naderi N, Lind F, BrismarK. Hyperbaric oxygen (HBO) therapy in treatmentof diabetic foot ulcers. Long-term follow-up. JDiabetes Complications. 2002;16(2):153-8.

79. Faglia E, Favales F, Aldeghi A, et al. Adjunctivesystemic hyperbaric oxygen therapy in treatmentof severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care.1996;19(12):1338-43.

80. Hoffmann G. Improvement of wound healing inchronic ulcers by hyperbaric oxygenation andby waterfiltered ultrared A induced localizedhyperthermia. Adv Exp Med Biol. 1994;345:181-8.

81. Niinikoski JH. Clinical hyperbaric oxygen therapy,wound perfusion, and transcutaneous oximetry.World J Surg. 2004;28(3):307-11.

82. Fife CE, Buyukcakir C, Otto GH, et al. Thepredictive value of transcutaneous oxygentension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients. WoundRepair Regen. 2002;10(4):198-207.

83. Niinikoski J. Hyperbaric oxygen therapy ofdiabetic foot ulcers, transcutaneous oxymetry inclinical decision making. Wound Repair Regen.2003;11(6):458-61.

84. Cosentino F, Sill JC, Katusic ZS. Role of superoxideanions in the mediation of endothelium-dependentcontractions. Hypertension. 1994;23(2):229-35.

85. Rao GN, Berk BC. Active oxygen species stimulatevascular smooth muscle cell growth and protooncogeneexpression. Circ Res. 1992;70(3):593-9.

86. Touyz RM, Schiffrin EL. Ang II-stimulatedsuperoxide production is mediated viaphospholipase D in human vascular smooth musclecells. Hypertension. 1999;34(4 Pt 2):976-82.

87. Zafari AM, Ushio-Fukai M, Akers M, et al. Roleof NADH/NADPH oxidase-derived H2O2 inangiotensin II-induced vascular hypertrophy.Hypertension. 1998;32(3):488-95.

88. Farquharson CA, Butler R, Hill A, Belch JJ,Struthers AD. Allopurinol improves endothelialdysfunction in chronic heart failure. Circulation.2002;106(2):221-6.

89. Harrison DG. Cellular and molecular mechanismsof endothelial cell dysfunction. J Clin Invest.1997;100(9):2153-7.

90. Zhilyaev SY, Moskvin AN, Platonova TF, GutsaevaDR, Churilina IV, Demchenko IT. Hyperoxicvasoconstriction in the brain is mediated byinactivation of nitric oxide by superoxide anions.Neurosci Behav Physiol. 2003;33(8):783-7.

91. Demchenko IT, Oury TD, Crapo JD, PiantadosiCA. Regulation of the brain’s vascular responses to oxygen. Circ Res. 2002;91(11):1031-7.

92. Ermak G, Davies KJ. Calcium and oxidative stress:from cell signaling to cell death. Mol Immunol.2002;38(10):713-21.

93. Lounsbury KM, Hu Q, Ziegelstein RC. Calciumsignaling and oxidant stress in the vasculature.Free Radic Biol Med. 2000;28(9):1362-9.

94. Tschudi MR, Mesaros S, Luscher TF, MalinskiT. Direct in situ measurement of nitric oxidein mesenteric resistance arteries. Increaseddecomposition by superoxide in hypertension.Hypertension. 1996;27(1):32-5.

95. Dennog C, Hartmann A, Frey G, Speit G. Detectionof DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis. 1996;11(6):605-9.

96. Dennog C, Radermacher P, Barnett YA, Speit G. Antioxidant status in humans after exposure tohyperbaric oxygen. Mutat Res. 1999;428(1-2):83-9.

97. Oury TD, Ho YS, Piantadosi CA, Crapo JD.Extracellular superoxide dismutase, nitric oxide,and central nervous system O2 toxicity. Proc NatlAcad Sci U S A. 1992;89(20):9715-9.

98. Zhiliaev S, Moskvin AN, Platonova TF, GutsaevaDR, Churilina IV, Demchenko IT. [Hyperoxicvasoconstriction in the brain is realized byinactivation of nitric oxide by superoxide anions].Ross Fiziol Zh Im I M Sechenova. 2002;88(5):553-9.

99. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G,Isimer A. Oxidative stress and nitric oxide relatedparameters in type II diabetes mellitus: effects ofglycemic control. Clin Biochem. 2001;34(1):65-70.

100. Koo JR, Vaziri ND. Effects of diabetes, insulin andantioxidants on NO synthase abundance and NOinteraction with reactive oxygen species. KidneyInt. 2003;63(1):195-201.

101. Efrati S, Dishy V, Averbukh M, et al. The effect ofN-acetylcysteine on renal function, nitric oxide,and oxidative stress after angiography. Kidney Int.2003;64(6):2182-7.

102. Xia Z, Nagareddy PR, Guo Z, Zhang W, McNeillJH. Antioxidant N-acetylcysteine restores systemicnitric oxide availability and corrects depressionsin arterial blood pressure and heart rate in diabeticrats. Free Radic Res. 2006;40(2):175-84.

103. Mayrovitz HN, Larsen PB. Functionalmicrocirculatory impairment: a possible sourceof reduced skin oxygen tension in human diabetesmellitus. Microvasc Res. 1996;52(2):115-26.

104. Haidara MA, Yassin HZ, Rateb M, Ammar H,Zorkani MA. Role of oxidative stress in developmentof cardiovascular complications in diabetesmellitus. Curr Vasc Pharmacol. 2006;4(3):215-27.

105. Feletou M, Vanhoutte PM. Endothelial dysfunction:a multifaceted disorder (The Wiggers AwardLecture). Am J Physiol Heart Circ Physiol.2006;291(3):H985-1002.

106. Tesfamariam B, Brown ML, Cohen RA. 15-Hydroxyeicosatetraenoic acid and diabeticendothelial dysfunction in rabbit aorta. J CardiovascPharmacol. 1995;25(5):748-55.

107. Lin KY, Ito A, Asagami T, et al. Impaired nitricoxide synthase pathway in diabetes mellitus: role ofasymmetric dimethylarginine and dimethylargininedimethylaminohydrolase. Circulation.2002;106(8):987-92.

108. Sowers JR. Hypertension, angiotensin II, andoxidative stress. N Engl J Med. 2002;346(25):1999-2001.

109. Laursen JB, Boesgaard S, Poulsen HE, AldershvileJ. Nitrate tolerance impairs nitric oxidemediatedvasodilation in vivo. Cardiovasc Res.1996;31(5):814-9.

110. Zhou ZH, Jiang JL, Peng J, Deng HW, Li YJ.Reversal of tolerance to nitroglycerin with Nacetylcysteineor captopril: a role of calcitoningene-related peptide. Eur J Pharmacol. 2002;439(1-3):129-34.

111. Efrati S, Berman S, Siman-Tov Y, et al. Nacetylcysteine attenuates NSAID-induced ratrenal failure by restoring intrarenal prostaglandinsynthesis. Nephrol Dial Transplant. 2007.

112. Ceron PI, Cremonez DC, Bendhack LM, TedescoAC. The relaxation induced by S-nitrosoglutathioneand S-nitroso-N-acetylcysteine in rataorta is not related to nitric oxide production. JPharmacol Exp Ther. 2001;298(2):686-94.

113. Muller B, Kleschyov AL, Stoclet JC. Evidence forN-acetylcysteine-sensitive nitric oxide storage asdinitrosyl-iron complexes in lipopolysaccharidetreatedrat aorta. Br J Pharmacol. 1996;119(6):1281-5.

114. Tepel M, van der Giet M, Statz M, Jankowski J,Zidek W. The antioxidant acetylcysteine reducescardiovascular events in patients with end-stagerenal failure: a randomized, controlled trial.Circulation. 2003;107(7):992-5.

115. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z.Hyperbaric oxygen preconditioning inducestolerance against spinal cord ischemia byupregulation of antioxidant enzymes in rabbits. JCereb Blood Flow Metab. 2006;26(5):666-74. 47. Yu SY, Chiu JH, Yang SD, et al. Preconditionedhyperbaric oxygenation protects the liver againstischemia-reperfusion injury in rats. J Surg Res.2005;128(1):28-36.

116. Cabigas BP, Su J, Hutchins W, et al. Hyperoxic andhyperbaric-induced cardioprotection: Role of nitricoxide synthase 3. Cardiovasc Res. 2006;72(1):143-51.

117. Hink J, Thom SR, Simonsen U, Rubin I, Jansen E.Vascular reactivity and endothelial NOS activityin rat thoracic aorta during and after hyperbaricoxygen exposure. Am J Physiol Heart Circ Physiol.2006.

118. Yu SY, Chiu JH, Yang SD, et al. Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats. J Surg Res. 2005;128(1):28-36.

119. Henshaw IN, Simpson A. Compressed Air as a Therapeutic Agent in the Treatment of Consumption, Asthma, Chronic Bronchitis and Other Diseases. Edinburgh: Sutherland and Knox; 1857.

120. Kindwall E, Whelan H. Hyperbaric Medicine Practice. 2nd ed. Flagstaff, AZ: Best Publishing Company; 2004:chap 1, 18, 19, 20, 25, 29, 30.

121. Feldmeier J. Hyperbaric Oxygen 2003: Indications and Results- The Hyperbaric Oxygen Therapy Committee Report. Kensington, Maryland: Undersea and Hyperbaric Medical Society, Inc.; 2003

122. Leslie CA, Sapico FL, Ginunas VJ, Adkins RH. Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care. Feb 1988;11(2):111-5. .

123. Boerema I, et al. Life without blood. A study of the influence of high atmospheric pressure and hypothermia on dilution of the blood. J Cardiovascular Surg. 1960;1:133-146.

124. Bassett BE, Bennett PB. Introduction to the physical and physiological bases of hyperbaric therapy. In: Hunt TK, Davis JC. Hyperbaric Oxygen Therapy. Bethesda, MD: Undersea Medical Society; 1977:11-24.

125. Bird AD, Telfer AB. Effect of Hyperbaric Oxygen on Limb Circulation. Lancet. Feb 13 1965;1(7381):355-6. .

126. Nylander G, Lewis D, Nordstrom H, et al. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg. Oct 1985;76(4):596-603. .

127. Sukoff MH, Ragatz RE. Hyperbaric oxygenation for the treatment of acute cerebral edema. Neurosurgery. Jan 1982;10(1):29-38. .

128. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. Aug 1981;90(2):262-70. .

129. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet. Oct 1972;135 (4):561-7. .

130. Mader JT, Brown GL, Guckian JC, et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis. Dec 1980;142(6):915-22. .

131. Park MK, Myers RA, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis. Mar 1992;14(3):720-40. .

132. Mandell GL. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun. Feb 1974;9(2):337-41. .

133. Zamboni WA, Roth AC, Russell RC, et al. The effect of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg. Oct 1989;5(4):343-7; discussion 349-50. .

134. Thom SR. Effects of hyperoxia on neutrophil adhesion. Undersea Hyperb Med. Spring 2004;31(1):123-31. .

135. Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol. Dec 1993;123(2):248-56. .

136. Thom SR. Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol Appl Pharmacol. Sep 1 1990;105(2):340-4. .

137. Van Unnika. Inhibition of toxin Production in Clostridium Perfringens in Vitro by Hyperbaric Oxygen. Antonie Van Leeuwenhoek. 1965;31:181-6. .

138. Mirhij NJ, Roberts RJ, Myers MG. Effects of hypoxemia upon aminoglycoside serum pharmacokinetics in animals. Antimicrob Agents Chemother. Sep 1978;14(3):344-7. .

139. Keck PE, Gottlieb SF, Conley J. Interaction of increased pressures of oxygen and sulfonamides on the in vitro and in vivo growth of pathogenic bacteria. Undersea Biomed Res. Jun 1980;7(2):95-106. .

140. Mendel V, Reichert B, Simanowski HJ, et al. Therapy with hyperbaric oxygen and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Undersea Hyperb Med. Fall 1999;26(3):169-74. .

141. Muhvich KH, Anderson LH, Criswell DW, et al. Hyperbaric hyperoxia enhances the lethal effects of amphotericin B in Leishmania braziliensis panamensis. Undersea Hyperb Med. Dec 1993;20(4):321-8. .

142. Harvey EN. Decompression sickness and bubble formation in blood and tissues. Bull NY Acad Med. 1945;21:505-36.

143. Brubakk A, Neuman T. Bennett and Elliott's Physiology and Medicine of Diving. 5th ed. Great Britain: Elsevier Science Limited; 2003:chap 10.

144. Bove A. Bove and Davis' Diving Medicine. 4th ed. Elsevier Inc.; 2004:chap 8, 10.

145. Neuman TS. Arterial gas embolism and decompression sickness. News Physiol Sci. Apr 2002;17:77-81. .

146. Navy Department. Diving Medicine and Recompression Chamber Operations. In: US Navy Diving Manual. 5. Rev 4. Washington DC: 1999.

147. Spencer MP. Decompression limits for compressed air determined by ultrasonically detected blood bubbles. J Appl Physiol. Feb 1976;40(2):229-35. .

148. Butler BD, Hills BA. Transpulmonary passage of venous air emboli. J Appl Physiol. Aug 1985;59(2):543-7. .

149. Abernathy CM, Dickinson TC. Massive air emboli from intravenous infusion pump: etiology and prevention. Am J Surg. Feb 1979;137(2):274-5. .

150. Khan M, Schmidt DH, Bajwa T, Shalev Y. Coronary air embolism: incidence, severity, and suggested approaches to treatment. Cathet Cardiovasc Diagn. Dec 1995;36(4):313-8. .

151. Michenfelder JD, Martin JT, Altenburg BM, et al. Air embolism during neurosurgery. An evaluation of right-atrial catheters for diagnosis and treatment. JAMA. May 26 1969;208(8):1353-8. .

152. Fong J, Gadalla F, Gimbel AA. Precordial Doppler diagnosis of haemodynamically compromising air embolism during caesarean section. Can J Anaesth. Mar 1990;37(2):262-4. .

153. Davies JM, Campbell LA. Fatal air embolism during dental implant surgery: a report of three cases. Can J Anaesth. Jan 1990;37(1):112-21. .

154. Brown SD, Piantadosi CA. Recovery of energy metabolism in rat brain after carbon monoxide hypoxia. J Clin Invest. Feb 1992;89(2):666-72. .

155. Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med. Apr 1995;25(4):474-80. .

156. Goulon MA, Barios M, Rapin M, Mouilhat F, Grobuis S, Labrousse J. Intoxicationoxy carbonee at anoxie aique par inhalation de gay de charbon et d'hydrocarbures. (English Translation). J Hyperbaric Med. 1986;1:23-41.

157. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. Oct 3 2002;347(14):1057-67. .

158. Raphael JC, Elkharrat D, Jars-Guincestre MC, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet. Aug 19 1989;2(8660):414-9. .

159. Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust. Mar 1 1999;170(5):203-10. .

160. Ducasse JL, Celsis P, Marc-Vergnes JP. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation?. Undersea Hyperb Med. Mar 1995;22(1):9-15. .

161. Grace TW, Platt FW. Subacute carbon monoxide poisoning. Another great imitator. JAMA. Oct 9 1981;246(15):1698-700. .

162. Barret L, Danel V, Faure J. Carbon monoxide poisoning, a diagnosis frequently overlooked. J Toxicol Clin Toxicol. 1985;23(4-6):309-13. .

163. Garland H, Pearce J. Neurological complications of carbon monoxide poisoning. Q J Med. Oct 1967;36(144):445-55. .

164. Winter PM, Miller JN. Carbon monoxide poisoning. JAMA. Sep 27 1976;236(13):1502. .

165. Hunt TK, Twomey P, Zederfeldt B, et al. Respiratory gas tensions and pH in healing wounds. Am J Surg. Aug 1967;114(2):302-7. .

166. Sheikh AY, Gibson JJ, Rollins MD, et al. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg. Nov 2000;135(11):1293-7. .

167. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care. Dec 1996;19(12):1338-43. .

168. Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med. Jul-Sep 1992;38(3):112-4, 111. .

169. Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised- controlled trial. Eur J Vasc Endovasc Surg. Jun 2003;25(6):513-8. .

170. Kalani M, Jorneskog G, Naderi N, et al. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications. Mar-Apr 2002;16(2):153-8. .

171. Perrins DJ. Influence of hyperbaric oxygen on the survival of split skin grafts. Lancet. Apr 22 1967;1(7495):868-71. .

172. Monies-Chass I, Hashmonai M, Hoere D, et al. Hyperbaric oxygen treatment as an adjuvant to reconstructive vascular surgery in trauma. Injury. May 1977;8(4):274-7. .

173. Greenwood TW, Gilchrist AG. Hyperbaric oxygen and wound healing in post-irradiation head and neck surgery. Br J Surg. May 1973;60(5):394-7. .

174. Reinisch JF. The pathophysiology of skin flap circulation. The delay phenomenon. Plast Reconstr Surg. Nov 1974;54(5):585-98. .

175. Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. Aug 1984;24(8):742-6. .

176. Skyhar MJ, Hargens AR, Strauss MB, et al. Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. J Bone Joint Surg Am. Oct 1986;68(8):1218-24. .

177. Schraibman IG, Ledingham IM. Hyperbaric oxygen and local vasodilatation in peripheral vascular disease. Br J Surg. Apr 1969;56(4):295-9. .

178. Illingworth CFW, Smith G, Lawson DD, et al. Surgical and physiological observations in an experimental pressure chamber. Br J Surg. 1961;49:222- 227.

179. Bartlett RL. Stroman RT, Nickels M, et al. Rabbit model of the use of fasciotomy and hyperbaric oxygenation in the treatment of compartment syndrome. UHMS (Suppl.). 1998;25:1095-1100.

180. Strauss MB, Hargens AR, Gershuni DH, Hart GB, Akeson WH. Delayed use of hyperbaric oxygen for treatment of a model anterior compartment syndrome. J Orthop Res. 1996;4:108-111.

181. Sonoda A, Maekawa Y, Arao T, et al. Spontaneous gangrene of the scrotum and penis (Fournier's gangrene). J Dermatol. Oct 1980;7(5):371-5. .

182. Stevens DL, Tweten RK, Awad MM, et al. Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis. Jul 1997;176(1):189-95. .

183. Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg. Feb 1984;119(2):199-204. .

184. Knighton DR, Fiegel VD, Halverson T, et al. Oxygen as an antibiotic. The effect of inspired oxygen on bacterial clearance. Arch Surg. Jan 1990;125 (1):97-100. .

185. Kaye D. Effect of hyperbaric oxygen on Clostridia in vitro and in vivo. Proc Soc Exp Biol Med. Feb 1967;124(2):360-6. .

186. Escobar SJ, Slade JB Jr, Hunt TK, et al. Adjuvant hyperbaric oxygen therapy (HBO2)for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med. Nov-Dec 2005;32(6):437-43. .

187. Gozal D, Ziser A, Shupak A, et al. Necrotizing fasciitis. Arch Surg. Feb 1986;121(2):233-5. .

188. Riseman JA, Zamboni WA, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. Nov 1990;108(5):847-50. .

189. Palmer JD. Neurosurgery 96. New York: Churchill Livingstone; 1996:875-79.

190. Alderson D, Strong AJ, Ingham HR, et al. Fifteen-year review of the mortality of brain abscess. Neurosurgery. Jan 1981;8(1):1-6. .

191. Brook I. Bacteriology of intracranial abscess in children. J Neurosurg. Apr 1981;54(4):484-8. .

192. Yang SY. Brain abscess: a review of 400 cases. J Neurosurg. Nov 1981;55(5):794-9. .

193. Dohrmann PJ, Elrick WL. Observations on brain abscess. Review of 28 cases. Med J Aust. Jul 24 1982;2(2):81-3. .

194. Miller JD, Fitch W, Ledingham IM, et al. The effect of hyperbaric oxygen on experimentally increased intracranial pressure. J Neurosurg. Sep 1970;33(3):287-96. .

195. Moody RA, Mead CO, Ruamsuke S, et al. Therapeutic value of oxygen at normal and hyperbaric pressure in experimental head injury. J Neurosurg. Jan 1970;32(1):51-4. .

196. Lampl L, Frey G, Bock KH. Hyperbaric oxygen in intracranial abscesses - update of a series of 13 patients. Undersea Biomed Res (Suppl.). 1992;19:83.

197. Rubin P. The Franz Buschke lecture: late effects of chemotherapy and radiation therapy: a new hypothesis. Int J Radiat Oncol Biol Phys. Jan 1984;10(1):5-34. .

198. Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. May 1983;41(5):283-8. .

199. Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. Jun 1983;41(6):351-7. .

200. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. Spring 2002;29(1):4-30. .

201. Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet. Sep 23 1995;346(8978):803-5. .

202. Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology. Apr 2005;65 (4):649-53. .

203. Feldmeier J, Carl U, Hartmann K, et al. Hyperbaric oxygen: does it promote growth or recurrence of malignancy?. Undersea Hyperb Med. Spring 2003;30(1):1-18. .

204. Niinikoski J, Hunt TK. Oxygen tensions in healing bone. Surg Gynecol Obstet. May 1972;134(5):746-50. .

205. Strauss MB, Malluche HH, Faugere MC. Effect of hyperbaric oxygen on bone resorption in rabbits. Seventh Annual Conference on Clinical Application of HBO. June 1982;Anaheim, California:8-18.

206. Davis JC, Gates GA, Lerner C, et al. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg. Jan 1992;118(1):89- 93. .

207. Hart GB, O'Reilly RR, Broussard ND, et al. Treatment of burns with hyperbaric oxygen. Surg Gynecol Obstet. Nov 1974;139(5):693-6. .

208. Niezgoda JA, Cianci P, Folden BW, et al. The effect of hyperbaric oxygen therapy on a burn wound model in human volunteers. Plast Reconstr Surg. May 1997;99(6):1620-5. .

209. Cianci P, Lueders HW, Lee H, et al. Adjunctive hyperbaric oxygen therapy reduces length of hospitalization in thermal burns. J Burn Care Rehabil. Sep-Oct 1989;10(5):432-5. .

210. Cianci P, Williams C, Lueders H, et al. Adjunctive hyperbaric oxygen in the treatment of thermal burns. An economic analysis. J Burn Care Rehabil. Mar-Apr 1990;11(2):140-3. .

211. Ketty SS, Schmidt CF. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Investigation. 1978;27:484-492.

212. Lambertsen CJ, Kough RH, Cooper DY, et al. Oxygen toxicity; effects in man of oxygen inhalation at 1 and 3.5 atmospheres upon blood gas transport, cerebral circulation and cerebral metabolism. J Appl Physiol. Mar 1953;5(9):471-86. .

213. Brozak J, Grande F. Body composition and basal metabolism in man correlation analysis versus physiologic approach. Human Biol. 1955;27:22-31.

214. Kiryu J, Ogura Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica. 1996;210(3):168-70. .

215. Krott R, Heller R, Aisenbrey S, et al. Adjunctive hyperbaric oxygenation in macular edema of vascular origin. Undersea Hyperb Med. Winter 2000;27 (4):195-204. .

216. Lotti T, Ghersetich I, Comacchi C et al. Cutaneous smallvesselvasculitis. J Am Acad Dermatol 1998; 39: 667–87.

217. Ryan TJ. Management issues in vasculitis. Adv Exp MedBiol 1999; 455: 327–30.

218. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanismsof action and outcomes. QJM 2004; 97: 385–95.

219. Roth RN, Weiss LD. Hyperbaric oxygen and wound healing.Clin Dermatol 1994; 12: 141–56.

220. Abidia A, Laden G, Kuhan G et al. The role of hyperbaricoxygen therapy in ischaemic diabetic lower extremityulcers: a double-blind randomised-controlled trial. Eur JVasc Endovasc Surg 2003; 25: 513–18.

221. Waisman D, Brod V, Wolff R et al. Effects of hyperoxia onlocal and remote microcirculatory inflammatory responseafter splanchnic ischemia and reperfusion. Am J PhysiolHeart Circ Physiol 2003; 285: H643–52.

222. Armstrong DG, Lavery LA, Harkless LB. Validation of adiabetic wound classification system. The contribution ofdepth, infection, and ischemia to risk of amputation. DiabetesCare 1998; 21: 855–9.

223. Boerema I, Meyne NG, Brummelkamp WH et al. [Lifewithout blood]. Ned Tijdschr Geneeskd 1960; 104: 949–54.

224. Grolman RE, Wilkerson DK, Taylor J et al. Transcutaneousoxygen measurements predict a beneficial response tohyperbaric oxygen therapy in patients with nonhealingwounds and critical limb ischemia. Am Surg 2001; 67:1072–9.

225. Kessler L, Bilbault P, Ortega F et al. Hyperbaric oxygenationaccelerates the healing rate of nonischemic chronicdiabetic foot ulcers: a prospective randomized study.Diabetes Care 2003; 26: 2378–82.

226. Haapaniemi T, Nylander G, Sirsjo A et al. Hyperbaricoxygen reduces ischemia-induced skeletal muscle injury.Plast Reconstr Surg 1996; 97: 602–7.

227. Tjarnstrom J, Wikstrom T, Bagge U et al. Effects of hyperbaricoxygen treatment on neutrophil activation and pulmonarysequestration in intestinal ischemia-reperfusion inrats. Eur Surg Res 1999; 31: 147–54.

228. Thom SR. Functional inhibition of leukocyte B2 integrinsby hyperbaric oxygen in carbon monoxide-mediatedbrain injury in rats. Toxicol Appl Pharmacol 1993; 123:248–56.

229. Kaelin CM, Im MJ, Myers RA et al. The effects of hyperbaricoxygen on free flaps in rats. Arch Surg 1990; 125:607–9.

230. Chen MF, Chen HM, Ueng SW et al. Hyperbaric oxygenpretreatment attenuates hepatic reperfusion injury. Liver1998; 18: 110–16.

231. Buras J. Basic mechanisms of hyperbaric oxygen in thetreatment of ischemia-reperfusion injury. Int AnesthesiolClin 2000; 38: 91–109.

232. Akin ML, Gulluoglu BM, Uluutku H et al. Hyperbaricoxygen improves healing in experimental rat colitis.Undersea Hyperb Med 2002; 29: 279–85.

233. Lavy A, Weisz G, Adir Y et al. Hyperbaric oxygen forperianal Crohn’s disease. J Clin Gastroenterol 1994; 19:202–5.

234. Sumen G, Cimsit M, Eroglu L. Hyperbaric oxygen treatmentreduces carrageenan-induced acute inflammation inrats. Eur J Pharmacol 2001; 431: 265–8.

235. Luongo C, Imperatore F, Cuzzocrea S et al. Effects ofhyperbaric oxygen exposure on a zymosan-induced shockmodel. Crit Care Med 1998; 26: 1972–6.

236. Fitzpatrick DT, Franck BA, Mason KT et al. Risk factors forsymptomatic otic and sinus barotrauma in a multiplacehyperbaric chamber. Undersea Hyperb Med 1999; 26: 243–7.

237. Plafki C, Peters P, Almeling M et al. Complications and sideeffects of hyperbaric oxygen therapy. Aviat Space EnvironMed 2000; 71: 119–24.

238. Marroni A, Oriani G, Wattel FE. Evaluation of cost-benefitand cost-efficiency of hyperbaric oxygen therapy. In:Handbook of Hyperbaric Medicine. Berlin: Springer-Verlag,1996: 879–86.